MetLife's Q2 Earnings Beat Reaffirms The Buy Case As Organic Growth Stands Out (NYSE:MET)
· seekingalpha.com
MetLife stock remains a Buy due to strong fundamentals, organic growth, and a resilient dividend. Click here to see MET's valuation upside to 2026 & key risks.
Albert Anthony is the pen name of a business author on Amazon and his newest book is "How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Tec...